CLINICAL TRIAL: NEURODEVELOPMENTAL / NEUROLOGICAL STUDY OF INFANTS/CHILDREN WITH

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得主要资金， 因此可以在其他CRISP条目中表示。所列机构为 中心，不一定是研究者的机构。 ACTG 219 本研究的目的是收集和研究有关您和您的医疗护理的临床和实验室信息，以增加我们对HIV感染孕妇及其子女的最佳护理的了解。这项研究将着眼于不同的药物在降低艾滋病病毒感染母亲所生婴儿感染艾滋病病毒的几率方面的效果。这项研究还将着眼于不同的药物如何降低血液中的病毒含量或增加帮助身体抵抗感染的血细胞。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. ACTG 219 The purpose of this study is to collect and study clinical and laboratory information about you and your medical care in order to increase our knowledge of the best care for HIV-infected pregnant women and their children. The study will look at how good different medications are in lowering the chance that a baby born to an HIV-infected mother will get HIV.The study will also look at how different medicines work to lower the amount of virus in the blood or increase the blood cells that help the body fight infection.